In 1994, researchers discovered a related orphan receptor with high homology to REV-ERBα, named NR1D2 or REV-ERBβ REV-ERBα/β proteins (12), essential components of the circadian clock, are widely expressed across tissues and have become key therapeutic targets for heart diseases (13). This evidence concerns the gene NR1D2 and heart disorder.